We were suffering from
influenza.
我们那时正遭受流感。
You should receive annual
influenza vaccinations.
你们应该每年接受流感疫苗接种。
I had to miss work this week because I came down with the
influenza.
我这周没法上班，因为我得了流感。
The
influenza virus is highly contagious, so it's essential to get vaccinated.
流感病毒非常传染，所以接种疫苗很重要。
The symptoms of
influenza include fever, cough, and body aches.
流感的症状包括发热、咳嗽和身体疼痛。
Influenza can be particularly dangerous for elderly people and those with weakened immune systems.
流感对老年人和免疫系统较弱的人尤其危险。
Every year, public health officials monitor the flu activity to determine the composition of the seasonal
influenza vaccine.
公共卫生官员每年都会监控流感活动，以确定季节性流感疫苗的组成。
The
influenza pandemic of 1918, also known as the Spanish Flu, was one of the deadliest in history." (1918年的流感大流行，也被称为西班牙流感，是历史上最致命的流感之一。
Antiviral medications can help alleviate the symptoms and shorten the duration of
influenza.
抗病毒药物可以帮助缓解症状并缩短流感的持续时间。
Good hygiene practices, such as washing your hands frequently, can help prevent the spread of
influenza.
良好的卫生习惯，如经常洗手，可以帮助防止流感的传播。
It's important to stay home when you have
influenza to avoid infecting others.
当你得了流感时，待在家里可以避免传染给他人。
Some people confuse the common cold with
influenza, but they are caused by different viruses and have differing severity levels.
有些人会把普通感冒和流感混淆，但它们是由不同的病毒引起的，严重程度也不同。
The company's vaccine plans involving such technology transfer and localized production cooperation mainly include those for hepatitis A, polio, influenza and COVID-19.
该公司涉及此类技术转让和本地化生产合作的疫苗计划主要包括针对甲型肝炎、脊髓灰质炎、流感和新冠肺炎的疫苗计划。
When influenza vaccination rates among school-age children in Shenzhen participating in the study increased from 42 percent to 76 percent, the vaccine could be an effective measure to slash the financial burden of hospitalization by 107 million yuan ($15.53 million).
当参与这项研究的深圳学龄儿童的流感疫苗接种率从42%提高到76%时，该疫苗可能是一项有效措施，可以减少1.07亿元（1553万美元）的住院经济负担。
Sinovac Biotech Ltd, a biopharmaceutical product provider in China, announced on Tuesday that a phase-3 clinical trial for its inactivated quadrivalent influenza vaccine was initiated in the Republic of Chile.
中国生物制药产品供应商科兴生物技术有限公司周二宣布，其四价流感灭活疫苗的三期临床试验已在智利共和国启动。
The clinical trial aims to evaluate the immunogenicity and safety of the quadrivalent influenza vaccine among individuals aged 3-year-old and above.
该临床试验旨在评估四价流感疫苗在3岁及以上人群中的免疫原性和安全性。
Half of them will receive one or two doses of the Sinovac vaccine, while the other half will receive a different quadrivalent influenza vaccine commercially available in Chile.
其中一半将接种一剂或两剂科兴疫苗，另一半将接种在智利上市的不同四价流感疫苗。
The study results are expected to provide further scientific evidence on the efficacy and safety of the company’s quadrivalent influenza vaccine to promote its worldwide use, Sinovac said.
科兴表示，该研究结果有望为该公司四价流感疫苗的有效性和安全性提供进一步的科学证据，以促进其在全球范围内的使用。
The quadrivalent influenza vaccine has been approved in China since June 2020. liuzhihua@chinadaily.
四价流感疫苗已于2020年6月在中国获批。liuzhihua@chinadaily.
Clover has also initiated development of additional vaccine programs including multivalent SARS-CoV-2 (covering multiple variants), rabies and influenza.
Clover也已开始开发其他疫苗项目，包括多价SARS-CoV-2（覆盖多种变体）、狂犬病和流感疫苗。
A kit that can test the novel coronavirus and the influenza virus at the same time and produce results in 30 minutes will be submitted for approval early next month, Shao said.
邵一鸣说，一款可以同时检测新冠病毒和流感病毒、并在30分钟内出具结果的检测试剂盒将于下月初提交审批。
At present, the platform has launched HPV, influenza and herpes zoster vaccination services.
目前，该平台已经推出了HPV（人乳头瘤病毒）、流感和带状疱疹疫苗接种服务。
As a third-time participant of the CIIE, Roche is showcasing a wide array of innovative products and therapies covering major diseases such as cancer immunotherapy, hematologic tumors, influenza and rare diseases.
作为第三届中国国际进口博览会的参展商，罗氏带来了涵盖重大疾病领域的众多创新产品和疗法，包括癌症免疫疗法、血液肿瘤、流感和罕见病等。
Swiss pharmaceutical company Roche has submitted approval application of an innovative influenza therapy to the Chinese drug authority, announced the company on Friday during the ongoing China International Import Expo.
瑞士制药巨头罗氏公司日前在首届中国国际进口博览会上宣布，已向中国药品监管部门提交了一种创新流感疗法的审批申请。
The therapy, the first and only single-dose oral drug approved for the treatment of influenza and the first anti-influenza drug approved by the United States Food and Drug Administration, is also being showcased at the expo.
这种疗法是首款且唯一获准用于治疗流感的单剂量口服药物，也是美国食品药品监督管理局批准的首种抗流感药物，它也在博览会上进行了展示。
The company's data showed that if a close contact of a flu patient takes the drug, the risk of him or her getting infected with influenza drops by 86 percent.
公司的数据显示，流感患者密切接触者如果服用该药物，其感染流感的风险会降低86%。
Yiling Pharma announced in May its Lianhuaqingwen capsules had been officially listed as Chinese proprietary medicine to treat influenza by the Healthy Sciences Authority of Singapore, which meant the Chinese medicine has been granted local market access.
According to the company, currently, the influenza case collection of the phase-II studies of Lianhuaqingwen capsules in the US has been completed, and its registration in countries and regions in the Middle East, Africa, and Latin America has started.
The study of the effectiveness of Lianhuaqingwen capsules in treating influenza had won the second prize in the National Award for Progress in Science and Technology in 2011, demonstrating its advantage in research and development.
The capsule, a traditional Chinese medicine used in the treatment of influenza, has been approved for sale as a medicine, food supplement or natural health product in a dozen countries and regions, including Brazil, Romania, Thailand and Ecuador.
Wang Junzhi, an academic at the Chinese Academy of Engineering, said China has laid a solid foundation to research inactivated vaccines in recent years, and inactivated vaccines have been widely used to fight hepatitis A, influenza, poliomyelitis, and hand, foot and mouth disease.
Switzerland-based Roche signed a strategic collaboration with the Boao Lecheng International Medical Tourism Pilot Zone in Hainan province during the CIIE on Wednesday to introduce a series of innovative drugs, including the first novel proposed mechanism to treat influenza approved by the United States Food and Drug Administration in nearly two decades, in the zone.
China's leading online healthcare platform DXY announced on Monday it is establishing a "China Influenza Prevention and Service Cloud Center" to leverage internet tools and big data technology for influenza prevention and control.
Data analysis co-conducted by the Chinese CDC and DXY revealed there is a positive correlation between the flu epidemic and doctors' research and learning behaviors online, providing a new idea for the prevention of influenza according to Qi Xiaopeng, deputy director of the global public health center of the Chinese CDC.
Data analysis also showed specific online research and learning behavior modes of doctors with varying expertise levels, in different disease departments and levels of hospitals during an influenza epidemic, which provides guidance for precise information service and educational tools to doctors.
With internet tools and big data technology used to analyze activity on DXY's medical academic and patient education platforms, the center aims to make surveillance of influenza more timely, comprehensive and accurate as a complement to the national infectious disease surveillance system, said Li Tiantian, founder of DXY.
"A review of history shows that crises have never been absent for China and ASEAN, be it the Asian financial crisis, the international financial crisis, SARS or H5N1 influenza.
While influenza cases are currently at high levels, Liu Tonghua, former deputy president of the Beijing University of Chinese Medicine, said that it is possible that people will see repeated infections of one or multiple pathogens simultaneously.
Swiss pharmaceutical company Roche — maker of innovative influenza drug Xofluza — said it has mobilized overseas supply chain resources to ensure stable quantities of the product in China, following a recent demand surge from both hospitals and pharmacies.
As influenza viruses spread, vaccine makers in China are speeding up efforts to guarantee supply, in order to safeguard citizens during the ongoing flu outbreak.
The country reported 420 influenza outbreaks from Nov 27 to Dec 3, a more than 4,100 percent surge from last year during the same period, said the Chinese National Influenza Center.
To tackle the problem, Sinovac said it offers the simultaneous administration of quadrivalent influenza split virion vaccine and 23-valent pneumococcal polysaccharide vaccine for adults aged 60 years and older, enhancing protection for the elderly.
While influenza and rhinovirus are the most prevalent among toddlers aged 1 to 4, for children aged 5 to 14, influenza, mycoplasma pneumoniae and adenovirus are common infections, Wang Huaqing, chief immunization planning expert at the Chinese Center for Disease Control and Prevention, said during a recent news conference.
Adults below the age of 60 are also susceptible to rhinovirus and COVID-19 infections, while the elderly are prone to getting infected with human metapneumovirus, which causes symptoms similar to influenza, as well as regular coronaviruses, he said.
During the recovery process, high incidence rates of influenza are a common phenomenon, resulting in surging demand for vaccines.
Data from the Chinese National Influenza Center show that the positivity rate of influenza across China continued to rise from Nov 27 to Dec 3.
The country reported 420 influenza outbreaks during the period, compared with 401 for the previous seven days.
On e-commerce delivery platforms, "type A influenza diagnostic kits" and "pneumonia-related diagnostic kits" have been selling fast.
These kits target several viruses — type A influenza virus, type B influenza virus, mycoplasma pneumonia virus and adenovirus.
BGI Genomics, an integrated solutions provider of precision medicine based in Shenzhen, Guangdong province, said demand for respiratory tract specimen testing has increased amid the ongoing influenza outbreak.
The point-of-care testing-based polymerase chain reaction technique detects 18 types of respiratory microbes, including type A and type B influenza viruses, adenovirus, rhinovirus, respiratory syncytial virus and others, all at once.
"There is high incidence of influenza, and many citizens with increased awareness about self-protection are actively purchasing various cold medicines for emergencies.
According to data from financial service provider Wind Info, the influenza index surged by 10.89 percent from Oct 27 to Nov 27.
"In recent years, the infection rates of influenza abroad, such as type A influenza and type B influenza, have been much higher than that before COVID-19.
Currently, apart from the COVID-19 vaccine and hepatitis-A vaccine, Sinovac owns Enterovirus Type 71 vaccine, which prevents hand-foot-mouth disease, combined hepatitis-A and B vaccine, H5N1 influenza vaccine, among others.
目前，除了COVID-19疫苗和甲型肝炎疫苗外，科兴公司还拥有预防手足口病的肠道病毒71型疫苗、甲乙型肝炎联合疫苗、H5N1型流感疫苗等。
It also launched HPV, influenza and shingles vaccination services.
它还推出了HPV、流感和带状疱疹疫苗接种服务。
Meanwhile, about 85 percent of companies related to veterinary drugs had also resumed production by Monday, while all manufacturers of vaccines for the highly pathogenic avian influenza and foot-and-mouth disease are operating, according to Wei.
Based on an agreement with the Shenzhen municipal government, the company even wants to turn Shenzhen into a hub to explore a new model for accelerating the launch of globally leading vaccines, improve the influenza vaccination rate, employ big data to establish a vaccination evaluation system, and delve more deeply into relevant research.
One path being pursued is disease prevention, especially those that are contagious like influenza or linked to lifestyle choices such as heart disease and diabetes.
Currently, the AI technology provided by Ping An Technology, the tech arm of Ping An Insurance (Group) Co Ltd, is helping healthcare authorities in Chongqing and Shenzhen, Guangdong province, to predict influenza outbreaks ahead of time with over 90 percent accuracy.
Industry reports noted that avian influenza, price increases of young chickens and changes in consumption habits may have an impact on the sector, and this in turn could cause fluctuations in both revenue and profit.
Based on scientific research, H1N1 influenza virus and coronavirus are both enveloped viruses.
"This suggests that the overall clinical consequences of Covid-19 may ultimately be more akin to those of a severe seasonal influenza, which has a case fatality rate of approximately 0.1 percent, or a pandemic influenza similar to those in 1957 and 1968 rather than to a disease similar to SARS or MERS, which had a case fatality rate of 9-to-10 percent and 36 percent, respectively," said the article.
Aside from vaccine companies, those associated with genetic technology, immunotherapy, generic drugs, cancer treatment, influenza treatment and private hospitals all saw declines.